case_id,Q0,Q1,Q2,Q3,Q4,Q5,Q6,Q7,Q8,Q9,Q10,Q10_followup,Q11,Q12,Q13,Q14,Q15,Q16,Q17
Case1,Whole exome sequencing (WES) to investigate potential genetic causes of neurodevelopmental delay and seizures,Yes,Yes,Yes,No,Yes,No,Yes,No,Yes,No,Diagnostic,Yes,No,Yes,Not listed,No,Yes,"Based on the policy, the following steps should be followed: 1) Ensure prior authorization is obtained before conducting the test; 2) Document that the patient meets medical necessity criteria including neurodevelopmental delay, seizures, and negative prior CMA testing; 3) Include documentation from the genetic counselor who ordered the test; 4) Submit clinical notes documenting the family history of neurodevelopmental disorders; 5) Include the results of the previous chromosomal microarray test showing it was negative; 6) Provide justification for how the test results will impact clinical management of the patient's condition."
